Lyvgen Biopharma
Lyvgen Biopharma is a Healthcare Company.
Launch date
Employees
Market cap
-
Enterprise valuation
€136m (Public information from Feb 2021)
Shanghai Shanghai (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$30.0m | Series B | ||
$20.0m Valuation: $150m | Series C | ||
| Total Funding | €45.5m | ||
Related Content
Recent News about Lyvgen Biopharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.